1.A Case of Granuloma Faciale Treated with Co2 Laser.
Mi Ran WHANG ; You Chan KIM ; Kyeong Han YOON ; Eun So LEE
Korean Journal of Dermatology 2001;39(10):1214-1216
Granuloma faciale is a rare disease of unknown origin characterized by single or multiple cutaneous nodules usually occurring on the face. A narrow grenz zone of normal dermis is usually observed between the epidermis and the dense dermal polymorphous infiltrates. We report a case of granuloma faciale in a 40-year-old male patient with erythematous plaque on his nose. The skin biopsy specimen showed a dense dermal accumulation of inflammatory cells, including neutrophils, eosinophils, monocytes, and lymphocytes. The infiltrate was distributed diffusely throughout the involved dermis and it focally involved the thinned and flattened epidermis. There is deposition of fibrinoid material within and around the affected lood wessels. The lesion was treated with CO2 laser effectively.
Adult
;
Biopsy
;
Dermis
;
Eosinophils
;
Epidermis
;
Granuloma*
;
Humans
;
Lasers, Gas*
;
Lymphocytes
;
Male
;
Monocytes
;
Neutrophils
;
Nose
;
Rare Diseases
;
Skin
2.Fatal Neutropenic Enterocolitis during Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Virus Infection.
Ji Hun KIM ; Jeong Won JANG ; Chan Ran YOU ; Si Young YOU ; Mun Kyung JUNG ; Jin Hwan JUNG
Gut and Liver 2009;3(3):218-221
It is known that neutropenia caused by combination pegylated interferon plus ribavirin therapy for hepatitis C virus (HCV) infection is well tolerated and carries a negligible risk of infection. Neutropenic enterocolitis is encountered most frequently in patients with hemato-oncologic diseases who are undergoing intensive chemotherapy. However, little information exists regarding this life-threatening event in the setting of HCV therapy. We present here an unusual case of fatal neutropenic enterocolitis in a cirrhotic patient receiving combination therapy for HCV infection. This is the first report of a death from neutropenic enterocolitis associated with treatment for chronic HCV infection. The present case suggests that caution should be exercised when continuing HCV therapy in neutropenic patients with advanced fibrosis, and the decision to maintain such therapy should be balanced against the potential for serious adverse events.
Enterocolitis, Neutropenic
;
Fibrosis
;
Hepacivirus
;
Hepatitis C
;
Hepatitis C, Chronic
;
Hepatitis, Chronic
;
Humans
;
Interferons
;
Neutropenia
;
Ribavirin
3.Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma.
Jeong Won JANG ; Seong Tae PARK ; Jung Hyun KWON ; Chan Ran YOU ; Jong Young CHOI ; Chan Kwon JUNG ; Si Hyun BAE ; Seung Kew YOON
Experimental & Molecular Medicine 2011;43(5):305-312
Although continuous low-dose (metronomic [MET]) therapy exerts anti-cancer efficacy in various cancer models, the effect of long-term MET therapy for hepatocellular carcinoma (HCC) remains unknown. This study assessed the long-term efficacy of MET on suppression of tumor growth and spontaneous metastasis in a rat model of HCC induced by administration of diethylnitrosamine for 16 wk. The rats were divided into 3 groups: MTD group received intraperitoneal (i.p.) injections of 40 mg/kg cyclophosphamide on days 1, 3, and 5 of a 21-day cycle; Control and MET groups received i.p. injections of saline and 20 mg/kg cyclophosphamide twice a week, respectively. Anti-tumor and anti-angiogenic effects and anti-metastatic mechanisms including matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) were evaluated. Twelve wk of MET therapy resulted in a significant reduction in intrahepatic tumors than control or MTD therapy. The MET group had fewer proliferating cell nuclear antigen-positive cells and decreased hypoxia-inducible factor-1alpha levels and microvessel density. Lung metastases were detected in 100%, 80%, and 42.9% in the control, MTD, and MET groups, respectively. MET therapy significantly decreased expression of TIMP-1, MMP-2 and -9. For mediators of pro-MMP-2 activation, MET therapy induced significant suppression in the TIMP-2 and MMP-14 level. The survival in the MET group was significantly prolonged compared to the control and MTD groups. Long-term MET scheduling suppresses tumor growth and metastasis via its potent anti-angiogenic properties and a decrease in MMPs and TIMPs activities. These results provide a rationale for long-term MET dosing in future clinical trials of HCC treatment.
Animals
;
Antineoplastic Agents/*administration & dosage/*pharmacology
;
Carcinoma, Hepatocellular/chemically induced/*drug therapy/mortality/pathology
;
Cell Proliferation/drug effects
;
Cyclophosphamide/*administration & dosage/*pharmacology
;
Diethylnitrosamine
;
Disease Models, Animal
;
Gene Expression Regulation, Neoplastic/*drug effects
;
Liver Cirrhosis/chemically induced
;
Liver Neoplasms/chemically induced/*drug therapy/mortality/pathology
;
Lung Neoplasms/drug therapy/pathology/secondary
;
Male
;
Matrix Metalloproteinases/metabolism
;
Neovascularization, Pathologic/enzymology/physiopathology
;
Rats
;
Rats, Sprague-Dawley
;
Survival Analysis
;
Tissue Inhibitor of Metalloproteinases/metabolism
;
Tumor Burden/drug effects
4.A case of hepatic epithelioid hemangioendothelioma that caused extrahepatic metastases without intrahepatic recurrence after hepatic resection.
Soung Won JEONG ; Hyun Young WOO ; Chan Ran YOU ; Won Hang HUH ; Si Hyun BAE ; Jong Young CHOI ; Seung Kew YOON ; Chan Kwon JUNG ; Eun Sun JUNG
The Korean Journal of Hepatology 2008;14(4):525-531
Epithelioid hemangioendothelioma is a neoplasm of vascular origin with a low-to-intermediate malignant potential and is one of the rare sarcomas arising from the liver. Its etiology is unknown and its clinical outcome is unpredictable. There is no generally accepted therapeutic strategy because of its rarity and the variable natural course between hemangioma and angiosarcoma. We report a case of a 64-year old woman who underwent hepatic resection due to epithelioid hemangioendothelioma in the right lobe that progressed to extrahepatic metastases of the bone, pleura, and peritoneum 22 months later. However, after resection there was no primary hepatic recurrence.
Bone Neoplasms/diagnosis/pathology/secondary
;
Female
;
Hemangioendothelioma, Epithelioid/*diagnosis/pathology/*secondary
;
Hepatectomy
;
Humans
;
Liver Neoplasms/*diagnosis/pathology
;
Lung Neoplasms/diagnosis/pathology/secondary
;
Middle Aged
;
Tomography, X-Ray Computed
5.Relative polycythemia associated with minimal change disease.
Jin Young KIM ; Young Shin SHIN ; Chan Ran YOU ; Cheol Whee PARK ; Young Jin CHOI ; Yoon Sik CHANG ; Byung Kee BANG
Korean Journal of Medicine 2004;67(Suppl 3):S799-S803
Hypovolemia and relative polycythemia is not an uncommon presentation in a child with nephrotic syndrome, but it is seldom mentioned in an adult. We experienced a case of hypovolemic shock and erythrocytosis in a patient with minimal change disease. Hypovolemia and polycythemia was corrected only after infusing isotonic fluid with albumin for 3 days. Hypovolemic shock is attributable to some of the following factors; suddenly decreased capillary oncotic pressure due to massive proteinuria, interstitial edema with tubular collapse, redistribution of renal blood flow, decreased glomerular filtration rate, and use of diuretics without albumin. In summary, 1) Relative polycythemia may occur as a result of hypovolemia in a patient with nephrotic syndrome but can be easily corrected by isotonic fluid and albumin. 2) An early detection of hypovolemia can be made by the measurement of central venous pressure, echocardiography, and the assessement of FeNa, U[k]/(U[Na]+U[K]). 3) Diuretics without albumin may result in transient developement of shock in patients with profound volume depletion.
Adult
;
Capillaries
;
Central Venous Pressure
;
Child
;
Diuretics
;
Echocardiography
;
Edema
;
Glomerular Filtration Rate
;
Humans
;
Hypovolemia
;
Nephrosis, Lipoid*
;
Nephrotic Syndrome
;
Polycythemia*
;
Proteinuria
;
Renal Circulation
;
Shock
6.Application of Helical Tomotherapy for Two Cases of Advanced Hepatocellular Carcinoma.
Joon Sung KIM ; Chan Ran YOU ; Jeong Won JANG ; Si Hyun BAE ; Jong Yong CHOI ; Seung Kew YOON ; Chul Seung KAY
The Korean Journal of Internal Medicine 2011;26(2):201-206
The role of radiotherapy in the treatment of hepatocellular carcinoma (HCC) has been limited to date, because the liver has a low tolerance to radiation. However, reconstructing tumors and surrounding organs via a three-dimensional conformal planning system can avoid excess radiotherapy exposure to the rest of the liver and adjacent organs. Recently, the concept of "adaptive radiotherapy," such as with helical tomotherapy, has been introduced for treating HCC. Helical tomotherapy obtains an image from the computed tomography component, which allows targeted regions to be visualized prior to, during, and immediately after each treatment and delivers intensity-modulated radiation therapy. We report two patients with advanced HCC who underwent tomotherapy treatment. One was a patient afflicted with advanced HCC and a portal vein tumor thrombus, which was treated with tomotherapy combined with transarterial chemolipiodolization. The other was a patient afflicted with multiple pulmonary metastases treated with tomotherapy followed by systemic chemotherapy.
Adult
;
Carcinoma, Hepatocellular/radiography/*radiotherapy/secondary
;
Chemotherapy, Adjuvant
;
Dose Fractionation
;
Female
;
Humans
;
Imaging, Three-Dimensional
;
Liver Neoplasms/pathology/radiography/*radiotherapy
;
Male
;
Neoplasm Invasiveness
;
Radiographic Image Interpretation, Computer-Assisted
;
*Radiotherapy Planning, Computer-Assisted
;
*Radiotherapy, Conformal
;
*Tomography, Spiral Computed
;
Treatment Outcome
7.Association Between Non-erosive Reflux Disease and High Risk of Obstructive Sleep Apnea in Korean Population.
Chan Ran YOU ; Jung Hwan OH ; Minji SEO ; Hye Yeon LEE ; Hyonsoo JOO ; Sung Hoon JUNG ; Sang Haak LEE ; Myung Gyu CHOI
Journal of Neurogastroenterology and Motility 2014;20(2):197-204
BACKGROUND/AIMS: Obstructive sleep apnea is becoming more important in gastroesophageal reflux disease (GERD) patients. This study investigated the prevalence of high risk for obstructive sleep apnea in GERD patients in comparison with that in healthy controls using the Berlin Questionnaire. We also investigated the risk factors for obstructive sleep apnea in GERD patients. METHODS: We enrolled 1,007 subjects: 776 healthy controls, 115 individuals with erosive reflux disease, and 116 with non-erosive reflux disease. GERD was diagnosed and classified using endoscopy and a reflux questionnaire. The Berlin Questionnaire was used to evaluate obstructive sleep apnea. RESULTS: More patients in the GERD group (28.2%) had higher risk for obstructive sleep apnea than healthy controls (20.4%, P = 0.036). More patients with non-erosive disease (32.8%) had higher risk for obstructive sleep apnea (OSA) than patients with erosive disease (20.9%) and controls (20.4%, P = 0.010). On multivariate analysis, non-erosive disease was a high risk factor for obstructive sleep apnea (odds ratio [OR], 1.82; P = 0.011). Age > or = 55 years (OR, 1.83; P < 0.001) and a high body mass index (> or = 25 kg/m2) (OR, 2.76; P < 0.001) were also identified as risk factors. Nocturnal GERD was related to high risk for OSA in non-erosive disease patients (OR, 2.97; P = 0.019), but not in erosive disease patients. CONCLUSIONS: High risk for OSA is more prevalent in GERD patients than in controls. Non-erosive reflux disease, age > or = 55, and a high BMI are associated with high risk for OSA.
Berlin
;
Body Mass Index
;
Endoscopy
;
Esophagitis
;
Gastroesophageal Reflux
;
Humans
;
Multivariate Analysis
;
Prevalence
;
Surveys and Questionnaires
;
Risk Factors
;
Sleep Apnea, Obstructive*
8.A Risk Factor for Wound Infection after Percutaneous Endoscopic Gastrostomy: Decreased Performance Status.
Chan Ran YOU ; Sang Woo KIM ; Chang Nyol PAIK ; Jae Myung PARK ; Yu Kyung CHO ; In Seok LEE ; Myung Gyu CHOI ; Kyu Yong CHOI ; In Sik CHUNG
Korean Journal of Gastrointestinal Endoscopy 2007;35(3):133-139
BACKGROUND/AIMS: Percutaneous endoscopic gastrostomy (PEG) has been widely used for long term enteral nutrition. The most common complication is peristomal wound infection. The aim of this study is to investigate the risk factors for peristomal wound infection after PEG. METHODS: We reviewed the records of 55 patients who had undergone PEG placement at Kangnam St. Mary's hospital via the Pull-string technique. We analyzed the underlying disease, the performance status and the nutritional state of the patients to determine the risk factors for wound infection. RESULTS: Peristomal wound infection after PEG occurred in 20 (36.4%) of the 55 patients. Methicillin resistant Staphylococcus aureus (MRSA) was the most common isolated microorganism. On univariate analysis, the underlying CNS disease, non-malignant disease and a decreased performance status (ECOG 3, 4) were correlated with wound infection. On multivariate analysis, a decreased performance status was an independent risk factor for wound infection after PEG (p=0.007, OR=6.011, CI: 1.64~22.09). CONCLUSIONS: A decreased performance status was an independent risk factor for peristomal wound infection after PEG.
Central Nervous System Diseases
;
Enteral Nutrition
;
Gastrostomy*
;
Humans
;
Methicillin Resistance
;
Multivariate Analysis
;
Risk Factors*
;
Staphylococcus aureus
;
Wound Infection*
;
Wounds and Injuries*
9.Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
Myeong Jun SONG ; Si Hyun BAE ; June Sung LEE ; Sung Won LEE ; Do Seon SONG ; Chan Ran YOU ; Jong Young CHOI ; Seung Kew YOON
The Korean Journal of Internal Medicine 2016;31(2):242-252
BACKGROUND/AIMS: We compared the recurrence of hepatocellular carcinoma (HCC) and the survival of patients who received radiofrequency ablation (RFA) after transarterial chemoembolization (TACE) with patients treated with TACE or RFA alone. METHODS: This study included 201 patients with HCC, who were consecutively enrolled at Seoul St. Mary's Hospital between December 2004 and February 2010. Inclusion criteria were a single HCC < or = 5.0 cm or up to three HCCs < or = 3.0 cm. We used a propensity score model to compare HCC patients (n = 87) who received RFA after TACE (TACE + RFA) with those who received TACE (n = 71) or RFA alone (n = 43). RESULTS: The median follow-up period was 33.3 months (range, 6.8 to 80.9). The TACE + RFA group showed significantly lower local recurrence than the RFA or TACE groups (hazard ratio [HR], 0.309; 95% confidence interval [CI], 0.130 to 0.736; p = 0.008; and HR, 0.352; 95% CI, 0.158 to 0.787; p = 0.011, respectively). The overall survival was significantly better in the TACE + RFA group compared to the RFA group (HR, 0.422; 95% CI, 0.185 to 0.964; p = 0.041). However, the survival benefit was not different between the TACE + RFA and TACE groups (p = 0.124). Subgroup analysis showed that among patients with a tumor size < 3 cm, the TACE + RFA group had significantly better long-term survival than those in the TACE or RFA groups (p = 0.017, p = 0.004, respectively). CONCLUSIONS: TACE + RFA combination treatment showed favorable local recurrence and better overall survival rates in early-stage HCC patients. Patients with tumors < 3 cm are likely to benefit more from TACE + RFA combination treatment. Additional studies are needed for the selection of suitable HCC patients for TACE + RFA treatment.
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Hepatocellular/mortality/pathology/*therapy
;
*Catheter Ablation/adverse effects/mortality
;
*Chemoembolization, Therapeutic/adverse effects/mortality
;
Chemotherapy, Adjuvant
;
Disease-Free Survival
;
Female
;
Humans
;
Kaplan-Meier Estimate
;
Liver Neoplasms/mortality/pathology/*therapy
;
Male
;
Middle Aged
;
*Neoadjuvant Therapy/adverse effects/mortality
;
Neoplasm Recurrence, Local
;
Neoplasm Staging
;
Patient Selection
;
Proportional Hazards Models
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Time Factors
;
Treatment Outcome
;
Tumor Burden
;
Young Adult
10.Chlamydophila pneumoniae enhances secretion of VEGF, TGF-beta and TIMP-1 from human bronchial epithelial cells under Th2 dominant microenvironment.
Chan Sun PARK ; Tae Bum KIM ; Keun Ae MOON ; Yun Jeong BAE ; Hee Ran LEE ; Min Kyoung JANG ; Hee Bom MOON ; You Sook CHO
Allergy, Asthma & Immunology Research 2010;2(1):41-47
PURPOSE: Chlamydophila pneumoniae infection in the airways is thought to be associated with the pathogenesis of asthma, especially in non-atopic severe asthma with irreversible airway obstruction that may be related to airway remodeling. Here, we investigated whether C. pneumoniae infection enhances the secretion of critical chemical mediators for airway remodeling, such as VEGF, TGF-beta, and TIMP-1, in human bronchial epithelial cells (BECs) in a Th2-dominant microenvironment. METHODS: Human bronchial epithelial cells (BEAS-2B cells) were infected with C. pneumoniae strain TW183 and cultured in both a Th1-dominant microenvironment with INF-gamma and a Th2-dominant microenvironment with IL-4 or IL-13 added to the culture medium. The VEGF, TGF-beta, and TIMP-1 levels in the culture supernatants were measured using enzyme-linked immunosorbent assays (ELISA). The activation of NF-kappaB in each experimental condition was determined using an electrophoretic mobility shift assay. RESULTS: Chlamydophila pneumoniae-infected BECs showed enhanced secretion of VEGF, TGF-beta, and TIMP-1 compared with non-infected BECs. The levels of cytokines secreted from BECs were increased more when IL-13 was added to the culture medium. C. pneumoniae-infected BECs also showed increased NF-kappaB activation. CONCLUSIONS: These results suggest that C. pneumoniae plays a role in the pathogenesis of airway remodeling in asthma, revealing a Th2-dominant immune response. Further studies are required to clarify the precise mechanism of C. pneumoniae infection in airway remodeling.
Airway Obstruction
;
Airway Remodeling
;
Asthma
;
Chlamydial Pneumonia
;
Chlamydophila
;
Chlamydophila pneumoniae
;
Cytokines
;
Electrophoretic Mobility Shift Assay
;
Enzyme-Linked Immunosorbent Assay
;
Epithelial Cells
;
Humans
;
Interleukin-13
;
Interleukin-4
;
NF-kappa B
;
Pneumonia
;
Sprains and Strains
;
Tissue Inhibitor of Metalloproteinase-1
;
Tissue Inhibitor of Metalloproteinases
;
Transforming Growth Factor beta
;
Vascular Endothelial Growth Factor A